0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Novel Approaches to Selective Treatments of Human Solid Tumors - Laboratory and Clinical Correlation (Paperback, Softcover reprint of the original 1st ed. 1993) Loot Price: R1,596
Discovery Miles 15 960
Novel Approaches to Selective Treatments of Human Solid Tumors - Laboratory and Clinical Correlation (Paperback, Softcover...

Novel Approaches to Selective Treatments of Human Solid Tumors - Laboratory and Clinical Correlation (Paperback, Softcover reprint of the original 1st ed. 1993)

Youcef M. Rustum

Series: Advances in Experimental Medicine and Biology, 339

 (sign in to rate)
Loot Price R1,596 Discovery Miles 15 960 | Repayment Terms: R150 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The therapeutic efficacy of FUra has been attributed to its incorporation into cellular RNA and, to its inhibition of thymidylate synthase, leading to potent inhibition of DNA synthesis and DNA damage. Studies of cell lines in vitro and model systems in vivo have demonstrated that although mechanisms of sensitivity and resistance to FUra are multifactorial, in the presence of citrovorum factor (LV, CF, 5-formyltetrahydrofolate) the site of action of FUr a becomes predominantly the pronounced and prolonged inhibition of thymidylate synthase. This action is the result of stabilization of the covalent ternary complex between FdUMP, an active metabolite of FUr a, 5, IO-methylenetetrahydrofolates, and thymidylate synthase. This effect of LV is thus an example of the concept of metabolic modulation. CF is commercially available as a racemic mixture of diastereoisomers (6R and 6S). The 6R isomer is considered to be biologically inactive; the 6S isomer is the biologically active form that is metabolized intracellularly to' form the various folate cofactor pools including 5, IO-methylenetetrahydrofolates. Although the extent of metabolism of folates in normal and tumor tissues has not been clearly delineated, it has been determined that the formation of folypolyglutamates is primarily a function of schedule of CF administration, while the retention of significant concentrations of reduced folate is a function of the dose and also the schedule of LV. Thus, it appears that for optimal modulation of FUra activity several factors must be considered simultaneously.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 339
Release date: March 2013
First published: 1993
Editors: Youcef M. Rustum
Dimensions: 254 x 178 x 17mm (L x W x T)
Format: Paperback
Pages: 319
Edition: Softcover reprint of the original 1st ed. 1993
ISBN-13: 978-1-4613-6060-5
Categories: Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Science & Mathematics > Biology, life sciences > Botany & plant sciences > General
Books > Science & Mathematics > Biology, life sciences > Zoology & animal sciences > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4613-6060-9
Barcode: 9781461360605

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners